ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.92
+0.06 (+2.10%)
As of Mar 25, 3:21 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +714.4% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.92
Current
$2.92
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
651.0%
Low target
Base Case
$23.78
+714.4%
Avg target
Bull Case
$37.21
+1,174.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.08
-90.0% from high
52-Week Low
$11.97
+-75.6% from low
Target vs 52W High
$23.78
-18.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%